Skip to main content
U.S. flag

An official website of the United States government

COVID-19

Coronavirus (COVID-19) is an illness caused by a virus that can spread from person to person. The virus that causes COVID-19 is a new coronavirus that has spread throughout the world. COVID-19 symptoms can range from mild (or no symptoms) to severe illness.

Federal Announcements

Biden-Harris Administration Awards $600 Million to Bolster US Manufacturing of COVID-19 Tests and Announces the Re-Opening of COVIDTests.gov

| Department of Health and Human Services (DHHS), Executive Office of the President | COVID-19, Supply Chain

The U.S. Department of Health and Human Services invested $600 million across 12 domestic COVID-19 test manufacturers and the reopening of COVIDTests.gov to deliver COVID-19 tests for free to households across the country. These investments in U.S. manufacturing will improve preparedness for COVID-19 and other pandemic threats of the future, strengthen the nation’s capacity to manufacture tests, and secure approximately 200 million new over-the-counter COVID-19 tests for future federal use.

Read more

Project NextGen Awards Over $1.4 Billion to Develop the Future of COVID-19 Vaccines and Therapeutics

| Department of Health and Human Services (DHHS) | COVID-19, Medical and Pharmaceutical

The U.S. Department of Health and Human Services awarded more than $1.4 billion for Project NextGen to support the development of a new generation of tools and technologies to protect against COVID-19. The awards follow extensive coordination with industry partners and include support for clinical trials that will enable the rapid development of more effective and longer-lasting coronavirus vaccines, a new monoclonal antibody and transformative technologies to streamline manufacturing processes.

Read more

Fact Sheet: HHS Announces ‘HHS Bridge Access Program For COVID-19 Vaccines and Treatments’ to Maintain Access to COVID-19 Care for the Uninsured

| Department of Health and Human Services (DHHS), Health Resources and Services Administration (HRSA) | COVID-19, Medical and Pharmaceutical

HHS is announcing the “HHS Bridge Access Program For COVID-19 Vaccines and Treatments Program’ to maintain broad access to COVID-19 vaccines for millions of uninsured Americans. The program will create a unique $1.1 billion public-private partnership to help maintain uninsured individuals’ access to COVID-19 care at their local pharmacies, through existing public health infrastructure, and at their local health centers.

Read more

Related Programs

Related Reports

  • Manufacturing USA Report to Congress: Fiscal Year 2021

    | COVID-19, Research and Development (R&D), Small and Medium-sized Manufacturers, Technology

    In FY 2021, the Manufacturing USA network collaborated across agencies and institutes to share research progress and discuss lessons learned from the COVID-19 pandemic. Under the American Rescue Plan appropriations, NIST-sponsored grant competitions will fund projects to Manufacturing USA institutes to focus on domestic research, development, and testbeds to prevent, prepare for, and respond to coronavirus.

    Read report

  • First Annual Report on Progress Towards Implementation of the American Pandemic Preparedness Plan

    | COVID-19, Healthcare, Medical and Pharmaceutical

    This document, released on the one-year anniversary of the public release of American Pandemic Preparedness: Transforming our Capabilities, provides the first annual report outlining progress towards implementation of relevant capabilities, highlights priority actions that are ongoing and needed across departments and agencies in the U.S. Government and the private sector, and identifies S&T opportunities to fill gaps and ensure that the Nation is properly prepared for emerging pandemic threats

    Read report

  • Public Health Supply Chain and Industrial Base: One-Year Report In Response to Executive Order 14017

    | COVID-19, Healthcare, Supply Chain

    The Coronavirus Disease 2019 (COVID-19) pandemic has significantly tested the U.S. public health supply chain and industrial base. It has strained global supply chains and exposed critical vulnerabilities in the Nation’s ability to deliver effective health care during times of high demand. Despite the challenges encountered since early 2020, the United States has made great progress to strengthen the public health supply chain and to address concerns regarding domestic manufacturing.

    Read report

  • Manufacturing USA Report to Congress: Fiscal Year 2020

    | COVID-19, Industrial Commons, Manufacturing USA, Small and Medium-sized Manufacturers, Technology, Workforce

    This annual report to Congress provides updates on the Manufacturing USA network response to COVID-19, as well as manufacturing technology development and workforce impacts from across the manufacturing innovation institutes.

    Read report

  • Manufacturing USA Rapid Response to COVID-19

    | COVID-19, Manufacturing USA, Supply Chain, Technology

    COVID-19 hit with a speed and force that commanded the best in government, academia, and industry to gather at an unprecedented pace and accelerate innovations to address the needs of our nation. In the earliest stages of the pandemic, the institutes in the Manufacturing USA network assessed the domestic manufacturing situation. Their analysis indicated an urgent need for better domestic supply chains, data analysis, and novel manufacturing products and processes.

    Read report